Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
M Iftekhar Ullah, Daniel M Riche & Christian A Koch. (2014) Transdermal testosterone replacement therapy in men. Drug Design, Development and Therapy 8, pages 101-112.
Read now
Read now
Prasanth Surampudi, Ronald S Swerdloff & Christina Wang. (2014) An update on male hypogonadism therapy. Expert Opinion on Pharmacotherapy 15:9, pages 1247-1264.
Read now
Read now
Claire Pexman-Fieth, Hermann M. Behre, Alvaro Morales, Natalia Kan-Dobrosky & Michael G. Miller. (2014) A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. The Aging Male 17:1, pages 1-11.
Read now
Read now
Articles from other publishers (16)
Abdulmaged M Traish. (2023) Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy – a narrative review. Sexual Medicine Reviews.
Crossref
Crossref
Milou Cecilia Madsen, Martin den Heijer, Claudia Pees, Nienke R Biermasz & Leontine E H Bakker. (2022) Testosterone in men with hypogonadism and transgender males: a systematic review comparing three different preparations. Endocrine Connections 11:8.
Crossref
Crossref
Magaly Aceves‐Martins, Richard Quinton, Miriam Brazzelli, Moira Cruickshank, Paul Manson, Jemma Hudson, Nick Oliver, Rodolfo Hernandez, Lorna Aucott, Frederick Wu, Waljit S. Dhillo, Siladitya Bhattacharya, Katie Gillies & Channa N. Jayasena. (2022) Identifying the outcomes important to men with hypogonadism: A qualitative evidence synthesis. Andrology 10:4, pages 625-641.
Crossref
Crossref
Glenn R Cunningham, Susan S Ellenberg, Shalender Bhasin, Alvin M Matsumoto, J Kellogg Parsons, Peter Preston, Jane A Cauley, Thomas M Gill, Ronald S Swerdloff, Christina Wang, Kristine E Ensrud, Cora E Lewis, Marco Pahor, Jill P Crandall, Mark E Molitch, Denise Cifelli, Shehzad Basaria, Susan J Diem, Alisa J Stephens-Shields, Xiaoling Hou & Peter J Snyder. (2019) Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial. The Journal of Clinical Endocrinology & Metabolism 104:12, pages 6238-6246.
Crossref
Crossref
L. Belkoff, G. Brock, D. Carrara, A. Neijber, M. Ando & J. Mitchel. (2018) Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. Andrologia 50:1, pages e12801.
Crossref
Crossref
Leon I. Igel, Rekha B. Kumar, Katherine H. Saunders & Louis J. Aronne. (2017) Practical Use of Pharmacotherapy for Obesity. Gastroenterology 152:7, pages 1765-1779.
Crossref
Crossref
James Anaissie, Natalie H. Roberts, Ping Wang & Faysal A. Yafi. (2017) Testosterone Replacement Therapy and Components of the Metabolic Syndrome. Sexual Medicine Reviews 5:2, pages 200-210.
Crossref
Crossref
Frans M.J. Debruyne, Hermann M. Behre, Claus G. Roehrborn, Mario Maggi, Frederick C.W. Wu, Fritz H. Schröder, Thomas Hugh Jones, Hartmut Porst, Geoffrey Hackett, Olivia A. Wheaton, Antonio Martin-Morales, Eric Meuleman, Glenn R. Cunningham, Hozefa A. Divan & Raymond C. Rosen. (2017) Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. BJU International 119:2, pages 216-224.
Crossref
Crossref
Mario Maggi, Frederick C.W. Wu, Thomas H. Jones, Graham Jackson, Hermann M. Behre, Geoffrey Hackett, Antonio Martin-Morales, Giancarlo Balercia, Adrian S. Dobs, Stefan T.E. Arver, Marcello Maggio, Glenn R. Cunningham, Andrea M. Isidori, Richard Quinton, Olivia A. Wheaton, Flora S. Siami & Raymond C. Rosen. (2016) Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME). International Journal of Clinical Practice 70:10, pages 843-852.
Crossref
Crossref
M. Efros, D. Carrara & A. Neijber. (2016) The efficacy, bioavailability and safety of a novel hydroalcoholic testosterone gel 2% in hypogonadal men: results from phase II open-label studies. Andrologia 48:6, pages 637-645.
Crossref
Crossref
Ling-yun HuiYa-wen WangFu-ling ZhouXian-cang MaRun-zhi YanLin ZhangQuan-li WangXuewen Yu. (2016) Association Between MKP-1, BDNF, and Gonadal Hormones with Depression on Perimenopausal Women. Journal of Women's Health 25:1, pages 71-77.
Crossref
Crossref
Ryan C. Owen, Osama O. Elkelany & Edward D. Kim. (2015) Testosterone supplementation in men. Current Opinion in Obstetrics & Gynecology 27:4, pages 258-264.
Crossref
Crossref
Ecem Kaya, Suresh C. Sikka & Serap Gur. (2015) A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction. The Journal of Sexual Medicine 12:4, pages 856-875.
Crossref
Crossref
Patricia J. Allen, Joseph F. DeBold, Maribel Rios & Robin B. Kanarek. (2015) Chronic high-dose creatine has opposing effects on depression-related gene expression and behavior in intact and sex hormone-treated gonadectomized male and female rats. Pharmacology Biochemistry and Behavior 130, pages 22-33.
Crossref
Crossref
De-Ying Kang & Hong-Jun Li. (2015) The Effect of Testosterone Replacement Therapy on Prostate-Specific Antigen (PSA) Levels in Men Being Treated for Hypogonadism. Medicine 94:3, pages e410.
Crossref
Crossref
Jenna McHenry, Nicole Carrier, Elaine Hull & Mohamed Kabbaj. (2014) Sex differences in anxiety and depression: Role of testosterone. Frontiers in Neuroendocrinology 35:1, pages 42-57.
Crossref
Crossref